Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 3
2007 6
2008 5
2009 3
2010 12
2011 8
2012 8
2013 8
2014 18
2015 19
2016 15
2017 21
2018 17
2019 20
2020 22
2021 23
2022 16
2023 14
2024 12
2025 22
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Results by year

Filters applied: . Clear all
Page 1
Neuregulins and cancer.
Montero JC, Rodríguez-Barrueco R, Ocaña A, Díaz-Rodríguez E, Esparís-Ogando A, Pandiella A. Montero JC, et al. Among authors: ocana a. Clin Cancer Res. 2008 Jun 1;14(11):3237-41. doi: 10.1158/1078-0432.CCR-07-5133. Clin Cancer Res. 2008. PMID: 18519747 Review.
Response.
Ocana A, Vera-Badillo F, Templeton A, Tannock I, Amir E. Ocana A, et al. J Natl Cancer Inst. 2015 Aug 17;107(10):djv244. doi: 10.1093/jnci/djv244. Print 2015 Oct. J Natl Cancer Inst. 2015. PMID: 26283612 No abstract available.
Clinical considerations for the design of PROTACs in cancer.
Nieto-Jiménez C, Morafraile EC, Alonso-Moreno C, Ocaña A. Nieto-Jiménez C, et al. Among authors: ocana a. Mol Cancer. 2022 Mar 7;21(1):67. doi: 10.1186/s12943-022-01535-7. Mol Cancer. 2022. PMID: 35249548 Free PMC article. Review.
Resistance to Antibody-Drug Conjugates.
García-Alonso S, Ocaña A, Pandiella A. García-Alonso S, et al. Among authors: ocana a. Cancer Res. 2018 May 1;78(9):2159-2165. doi: 10.1158/0008-5472.CAN-17-3671. Epub 2018 Apr 13. Cancer Res. 2018. PMID: 29653942 Review.
Refining Early Antitumoral Drug Development.
Ocaña A, García-Alonso S, Amir E, Pandiella A. Ocaña A, et al. Trends Pharmacol Sci. 2018 Nov;39(11):922-925. doi: 10.1016/j.tips.2018.09.003. Epub 2018 Sep 29. Trends Pharmacol Sci. 2018. PMID: 30279003 Review.
Understanding the Preclinical Efficacy of Antibody-Drug Conjugates.
Díaz-Tejeiro C, López de Sá A, Poyatos-Racionero E, Ballestín P, Bartolomé J, Calvo E, Moreno V, Moris F, Pérez-Segura P, Gyorffy B, Pandiella A, Ocaña A. Díaz-Tejeiro C, et al. Among authors: ocana a. Int J Mol Sci. 2024 Nov 29;25(23):12875. doi: 10.3390/ijms252312875. Int J Mol Sci. 2024. PMID: 39684584 Free PMC article. Review.
255 results